Featured News
AIM Blog
Investing in the Fight Against Alzheimer’s
Nearly 7 million Americans are currently living with Alzheimer’s — a number expected to rise to nearly 13 million by 2050 without medical breakthroughs. Thankfully, Congress has taken action over the ...
All News
Press Release
Senate HELP Committee Advances Bipartisan Legislation to Renew Nation’s Commitment to Addressing the Alzheimer’s Crisis
NAPA Reauthorization Act and Alzheimer’s Accountability and Investment Act Washington, D.C., June 15, 2023 — Today the Senate Committee on...
Press Release
FDA Advisory Committee Unanimously Confirms Efficacy and Clinical Benefit of Leqembi for Early Alzheimer's Disease
CHICAGO, June 9, 2023 — Today, an Advisory Committee to the Food and Drug Administration (FDA) unanimously endorsed the efficacy...
AIM Blog
Recognizing AIM’s June Advocate of the Month: Mike Razzi
Each month, we’re featuring an advocate who engages with policymakers to ensure priorities that improve the lives of people impacted...
Press Release
Alzheimer’s Association Statement on CMS Announcement of Registry for Access to FDA-Approved Alzheimer’s Treatments
The Alzheimer’s Association recognizes that the Centers for Medicare & Medicaid Services (CMS) has announced their conceptual approach to fulfill...
Press Release
Alzheimer’s Association Statement on Announcement of Rosalynn Carter’s Dementia Diagnosis
The Alzheimer’s Association expresses our deepest appreciation to former First Lady Rosalynn Carter and her family for sharing her diagnosis...
AIM Blog
Alzheimer’s Advocates Rally for CMS to “Fix This Mess” and Stop Blocking Access to Alzheimer’s Treatments
In communities across the nation, passionate Alzheimer’s advocates put on their purple, picked up their signs and rallied for access...